Loss of microRNA ‐21 leads to profound stromal remodeling and short survival in K‐Ras ‐driven mouse models of pancreatic cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Loss of
microRNA
‐21 leads to profound stromal remodeling and short survival in
K‐Ras
‐driven mouse models of pancreatic cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-05-10
DOI
10.1002/ijc.33041
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Molecular subtypes of pancreatic cancer
- (2019) Eric A. Collisson et al. Nature Reviews Gastroenterology & Hepatology
- Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts
- (2019) Ela Elyada et al. Cancer Discovery
- Personalized RNA Medicine for Pancreatic Cancer
- (2018) Maud-Emmanuelle Gilles et al. CLINICAL CANCER RESEARCH
- Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies
- (2018) Herbert Hurwitz et al. INVESTIGATIONAL NEW DRUGS
- miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy
- (2018) Jiajia Xi et al. ONCOGENE
- Micro-RNA-21 Regulates Cancer-Associated Fibroblast-Mediated Drug Resistance in Pancreatic Cancer
- (2018) Lulin Zhang et al. ONCOLOGY RESEARCH
- A Phase Ib study of ruxolitinib + gemcitabine ± nab-paclitaxel in patients with advanced solid tumors
- (2018) Todd Bauer et al. OncoTargets and Therapy
- The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma
- (2018) Le Ren et al. Therapeutics and Clinical Risk Management
- The Paradoxical Web of Pancreatic Cancer Tumor Microenvironment
- (2018) Kelly J. Lafaro et al. AMERICAN JOURNAL OF PATHOLOGY
- IL-1-induced JAK/STAT signaling is antagonized by TGF-beta to shape CAF heterogeneity in pancreatic ductal adenocarcinoma
- (2018) Giulia Biffi et al. Cancer Discovery
- Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
- (2017) Daniel Öhlund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- MiR-21 is required for anti-tumor immune response in mice: an implication for its bi-directional roles
- (2017) W He et al. ONCOGENE
- miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice
- (2017) Pedro M Rodrigues et al. Cell Death & Disease
- Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous Neoplasm
- (2017) Krushna C Patra et al. Clinical and Translational Gastroenterology
- Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS
- (2016) Wanglong Qiu et al. GASTROENTEROLOGY
- MicroRNA-21 promotes TGF-β1-induced epithelial-mesenchymal transition in gastric cancer through up-regulating PTEN expression
- (2016) Chang Li et al. Oncotarget
- TGF-β1 promotes scar fibroblasts proliferation and transdifferentiation via up-regulating MicroRNA-21
- (2016) Ying Liu et al. Scientific Reports
- Pancreatic cancer
- (2016) Jorg Kleeff et al. Nature Reviews Disease Primers
- Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed
- (2015) Herbert I. Hurwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer
- (2015) Daniel V.T. Catenacci et al. JOURNAL OF CLINICAL ONCOLOGY
- Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
- (2015) Richard A Moffitt et al. NATURE GENETICS
- The oncogenic microRNA miR-21 promotes regulated necrosis in mice
- (2015) Xiaodong Ma et al. Nature Communications
- Stromal Expression of miR-21 Identifies High-Risk Group in Triple-Negative Breast Cancer
- (2014) Todd A. MacKenzie et al. AMERICAN JOURNAL OF PATHOLOGY
- Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
- (2014) Berna C. Özdemir et al. CANCER CELL
- Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
- (2014) Andrew D. Rhim et al. CANCER CELL
- Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy
- (2014) Mara H. Sherman et al. CELL
- Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma
- (2014) E. J. Kim et al. CLINICAL CANCER RESEARCH
- Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways
- (2014) Ivan G. Gomez et al. JOURNAL OF CLINICAL INVESTIGATION
- Stromal MicroRNA-21 levels predict response to 5-fluorouracil in patients with pancreatic cancer
- (2014) Timothy R. Donahue et al. JOURNAL OF SURGICAL ONCOLOGY
- Stromal response to Hedgehog signaling restrains pancreatic cancer progression
- (2014) J. J. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interaction of the oncogenic miR-21 microRNA and the p53 tumor suppressor pathway
- (2013) Xiaodong Ma et al. CARCINOGENESIS
- Genetically engineered mouse models of pancreatic adenocarcinoma
- (2013) Carmen Guerra et al. Molecular Oncology
- MicroRNA-21 Knockout Improve the Survival Rate in DSS Induced Fatal Colitis through Protecting against Inflammation and Tissue Injury
- (2013) Chenzhang Shi et al. PLoS One
- MicroRNA-21 in Pancreatic Ductal Adenocarcinoma Tumor-Associated Fibroblasts Promotes Metastasis
- (2013) Brian E. Kadera et al. PLoS One
- Ovarian cancer progression is controlled by phenotypic changes in dendritic cells
- (2012) Uciane K. Scarlett et al. JOURNAL OF EXPERIMENTAL MEDICINE
- MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways
- (2012) B. N. Chau et al. Science Translational Medicine
- A novel 3-dimensional culture system uncovers growth stimulatory actions by TGFβ in pancreatic cancer cells
- (2011) Lorenzo F. Sempere et al. CANCER BIOLOGY & THERAPY
- Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis
- (2011) X. Ma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
- (2010) Mark E. Hatley et al. CANCER CELL
- Fluorescence-Based Codetection with Protein Markers Reveals Distinct Cellular Compartments for Altered MicroRNA Expression in Solid Tumors
- (2010) L. F. Sempere et al. CLINICAL CANCER RESEARCH
- MicroRNA-21 Is Induced Early in Pancreatic Ductal Adenocarcinoma Precursor Lesions
- (2010) M. C. du Rieu et al. CLINICAL CHEMISTRY
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- Inactivation of TIF1γ Cooperates with KrasG12D to Induce Cystic Tumors of the Pancreas
- (2009) David F. Vincent et al. PLoS Genetics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started